Aurobindo Shares Soar 4% as USFDA Classifies Facility as VAI
Shares of Aurobindo Pharma Ltd soared roughly 4% on Wednesday, 6 May, after the company said that the US Food and Drug Administration (USFDA) has...
Tag : Aurobindo Pharma Ltd
Aurobindo Pharma Hits 52-Week High on Twin USFDA Approvals
Shares of Aurobindo Pharma Limited touched a 52-week high of Rs 1,396.60 on the BSE on 20 April, rising 0.79% from the previous close of...
Aurobindo Pharma Bags USFDA Nod for Rare Disease Liquid Drug
Shares of Aurobindo Pharma Limited edged up on 17 April after the company secured final approval from the US Food and Drug Administration for Glycerol...
Aurobindo Pharma Shares Soar 3% as Arm Secures VAI from USFDA
Shares of Aurobindo Pharma Ltd soared 3% on 20 March after the company announced that its wholly owned subsidiary, Apitoria Pharma Pvt Ltd, has acquired...
Aurobindo Pharma Gains 2.5% After USFDA Approval
Shares of Aurobindo Pharma Ltd surged 2.5% to hit a day’s high of Rs 1,250.90 on 26th February. This happened after the company said its...
Aurobindo Unit 7 Gets 9 FDA Observations; Shares Rise 2.75%
Shares of Aurobindo Pharma Ltd surged 2.75% to touch a day’s high of Rs 1,161 on 11th February. This came after the company said the...
Aurobindo Pharma Shares Trade Lower as Arm Secures 11 Observations
Shares of Aurobindo Pharma Ltd were trading in the red and 1% lower on 9 February after the US Food and Drug Administration (USFDA) inspected...
Aurobindo Pharma Shares Slump 1% on 8 USFDA Observations
Shares of Aurobindo Pharma Ltd were trading almost 1% lower on Monday, 8 September, after the company received eight observations from the United States Food...
Aurobindo Pharma Shares Slump 2% on Securing Approval in the UK
Shares of Aurobindo Pharma Ltd were trading almost 2% lower on Tuesday, 26 August, despite its subsidiary gaining regulatory approval in the United Kingdom to...
Pharma Shares Crash Trump Issues Letter for Lowered Prices
Shares of prominent pharmaceutical companies fell substantially as investors assessed the impact of US President Trump’s letter to 17 global drug majors requesting that they...